In Figure 4C, ALDH4A1 deficiency leads to the accumulation of proline, which sustains the proliferation and survival of CRC cells (Alaqbi et al., 2022), and MT3 plays a pivotal role in tumor formation, progression, and drug resistance (Si and Lang, 2018). Here, ALDH4A1 is linked to neoplasm.